Evidence map›Paper›PMID 30575774›Full record

ArticleScientific reports2018

Lactoferrin and lactoferricin endocytosis halt Giardia cell growth and prevent infective cyst production.

Lorena S Frontera, Sofía Moyano, Gonzalo Quassollo, Adriana Lanfredi-Rangel, Andrea S Rópolo, María C Touz

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.0field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 40 citations in OpenAlex.

  1. Article
  2. Article
  3. Frontiers in immunology · 2026
    Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Lactoferrin as a Human Genome "Guardian"-An Overall Point of View.International journal of molecular sciences · 2022
    Review
  13. Article
  14. Review
  15. Review
  16. Staging Encystation Progression inFrontiers in cell and developmental biology · 2021
    Article
  17. Review
  18. Article
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Lorena S FronteraInstituto de Investigación Médica Mercedes y Martín Ferreyra, INIMEC - CONICET, Universidad Nacional de Córdoba, Córdoba, 5000, Argentina.
Sofía MoyanoInstituto de Investigación Médica Mercedes y Martín Ferreyra, INIMEC - CONICET, Universidad Nacional de Córdoba, Córdoba, 5000, Argentina.
Gonzalo QuassolloInstituto de Investigación Médica Mercedes y Martín Ferreyra, INIMEC - CONICET, Universidad Nacional de Córdoba, Córdoba, 5000, Argentina.
Adriana Lanfredi-RangelServiço de Microscopia Eletrônica, Centro de Pesquisas Gonçalo Moniz, Fiocruz-Ba, 40296-710, Brazil.
Andrea S RópoloInstituto de Investigación Médica Mercedes y Martín Ferreyra, INIMEC - CONICET, Universidad Nacional de Córdoba, Córdoba, 5000, Argentina.
María C TouzInstituto de Investigación Médica Mercedes y Martín Ferreyra, INIMEC - CONICET, Universidad Nacional de Córdoba, Córdoba, 5000, Argentina. ctouz@immf.uncor.edu.ORCID http://orcid.org/0000-0002-6769-6896
Consejo Nacional de Investigaciones Científicas y Técnicas · ARFundação Oswaldo Cruz · BR

Funding

Ministerio de Ciencia, Tecnología e Innovación Productiva (Ministry of Science, Technology and Productive Innovation, Argentina) pict2013-1122
6 · The paper itself

Abstract

Lactoferrin (LF) is an 80 KDa iron-binding glycoprotein that plays a significant role in the innate immune system and is considered to be an important microbicide molecule. It has been suggested to be effective in the treatment of giardiasis, an intestinal disease caused by the protozoan parasite G. lamblia. However, the molecular mechanisms by which LF exerts its effect on this parasite are unknown. Most of the microbicidal activity of human or bovine LF (hLF or bLF) has been associated with the N-terminal region of the mature LF - lactoferricin (LFcin). LFcin is produced by pepsin cleavage of the native protein in vitro and likely in vivo. In this work, we analyse the participation of the endocytic machinery of G. lamblia in the internalization of bLF and bLFcin and their effects on cell homeostasis. Our results show that, when bLF or bLFcin are internalized by receptor-mediated endocytosis, cell growth stops, and morphological changes are produced in the trophozoites, which ultimately will produce immature cysts. Our findings contribute to disclose the fine mechanism by which bLF and bLFcin may function as an antigiardial molecule and why they have therapeutic potential to eradicate giardiasis.

Indexed as

AnimalsCattleCell ProliferationCells, CulturedCystsDose-Response Relationship, DrugEndocytosisGiardiaGiardiasisHumansLactoferrinProtein BindingReceptors, LDLlactoferricin BLactoferrinLTF protein, humanReceptors, LDL

Identifiers

PMID30575774
PMCPMC6303297
OpenAlexW2903877211

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.